News: cancer
Study reveals Indigenous ÐÓ°ÉÖ±²¥ns at higher risk of HPV throat cancers
Researchers from the ÐÓ°ÉÖ±²¥ of Adelaide have found that throat cancers caused by human papilloma virus (HPV), a common sexually transmitted disease, are 15 times more prevalent in Indigenous ÐÓ°ÉÖ±²¥ns than young non-Indigenous ÐÓ°ÉÖ±²¥ns, and five times the prevalence reported in a systematic review involving the US, Brazil, Mexico and Finland.
[Read more about Study reveals Indigenous ÐÓ°ÉÖ±²¥ns at higher risk of HPV throat cancers]
Arthritis drug used to limit antibiotics in blood cancer patients
Researchers from the ÐÓ°ÉÖ±²¥ of Adelaide and the Radboud ÐÓ°ÉÖ±²¥ Medical Centre in the Netherlands have repurposed an arthritis drug to restrict the use of antibiotics in the treatment of side effects caused by blood cancer, including leukaemia, lymphoma and myeloma.
[Read more about Arthritis drug used to limit antibiotics in blood cancer patients]
Leading cancer researcher joins SAiGENCI
Cancer research expert Professor Melissa Davis has been appointed as Program Leader, Cancer Systems Biology at the South ÐÓ°ÉÖ±²¥n immunoGENomics Cancer Institute (SAiGENCI).
Medical research funding boost has wide impact
ÐÓ°ÉÖ±²¥ of Adelaide experts have been awarded more than $1.9 million to pursue medical research that will improve the lives of people such as young Aboriginal women, high-risk COVID-19 groups and cancer sufferers.
[Read more about Medical research funding boost has wide impact]
Cancer treatment ‘brain-gain’ for South ÐÓ°ÉÖ±²¥
South ÐÓ°ÉÖ±²¥n patients with cancer will benefit from world-class cancer research and new treatments with the appointment of three globally-lauded scientists to the ÐÓ°ÉÖ±²¥ of Adelaide’s South ÐÓ°ÉÖ±²¥n immunoGENomics Cancer Institute (SAiGENCI).
[Read more about Cancer treatment ‘brain-gain’ for South ÐÓ°ÉÖ±²¥]
State-of-the-art Cancer Institute to deliver world-leading research and treatment for South ÐÓ°ÉÖ±²¥ns
World-leading patient care, cutting-edge cancer diagnoses and treatments – including genomic and immune-based technologies – combined with ground-breaking research collaborations, will be the focus of a new cancer institute in South ÐÓ°ÉÖ±²¥.
Starving gut bacteria to improve chemotherapy outcomes
Fasting before chemotherapy drastically increases the number and diversity of bacteria found in the gut and can improve treatment outcomes, a new study by ÐÓ°ÉÖ±²¥ of Adelaide researchers has found.Â
[Read more about Starving gut bacteria to improve chemotherapy outcomes ]
$1.62 million for rare cancer research
A ÐÓ°ÉÖ±²¥ of Adelaide and SAHMRI study to test new treatments for a rare and neglected blood cancer, which has no known effective treatment, has been awarded $1,619,122 from the Federal Government’s Medical Research Future Fund (MRFF).
Partnership to revolutionise cancer diagnosis
The ÐÓ°ÉÖ±²¥ of Adelaide has partnered with medical technology company Sienna Cancer Diagnostics in an exclusive worldwide licencing agreement to develop a unique cancer probe with the potential to detect a sugar molecule only present in cancer cells.
[Read more about Partnership to revolutionise cancer diagnosis]
United front to Beat Cancer
Two up-and-coming young researchers from the ÐÓ°ÉÖ±²¥ of Adelaide and SAHMRI are major beneficiaries of the latest round of Cancer Council SA’s Beat Cancer Project funding.
![RSS News Feed](/global/images/rss.gif" "RSS News Feed"){kind=small}